Skip to content

The mechanism of sanhuang anti-inflammatory prescription in treating diabetic foot

The mechanism of sanhuang anti-inflammatory prescription in treating diabetic foot

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052877
Enrollment
Unknown
Registered
2021-11-06
Start date
2021-11-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic foot

Interventions

Placebo group:On the basis of conventional treatment, placebo was given, 1 sachet each time, 2 times a day, taken with water
Experimental group:On the basis of conventional treatment, give sanhuang anti-inflammatory prescription, 1 packet each time, 2 times a day, take with water

Sponsors

Shanghai TCM-Integrated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Both male and female are acceptable; 2. Meet the diagnostic criteria for diabetic foot in the 2020 China Diabetes Prevention and Control Guidelines; meet the diagnostic criteria for muscle gangrene in the Quality Control Standards for Diabetic Foot Muscle Single Disease (identified by the Shanghai Municipal Science and Technology Commission in 1999); 3. Meet the diagnosis of damp-heat syndrome of muscle gangrene in Traditional Chinese Medicine; 4. Aged >= 18 years; 5. Voluntarily join the clinical trial research and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Organic mental disorders, or psychoactive substances and non-addictive substances; 2. Women who are pregnant, breastfeeding, or may become pregnant in the study and cannot take effective contraceptive measures; 3. Patients who refuse to accept TCM treatment; 4. Those with obvious symptoms of heart, liver, kidney or other systems and need emergency treatment.

Design outcomes

Primary

MeasureTime frame
Blood gulcose;Blood lipid;Urinalysis;Foot blood flow measurement;Hepatic and renal function;Hemoglobulin;Electrolyte;Myocardial enzyme;Glycosylated hemoglobin;Electrocardiograph;Inflammatory factors;

Countries

China

Contacts

Public ContactZhang Zhihui

Shanghai TCM-Integrated Hospital, Shanghai University of TCM

463771087@qq.com+86 13761144924

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026